The Role of Peri-operative Chemotherapy for Resectable Colorectal Liver Metastasis: What Does the Evidence Support?

被引：9
|
作者：
Pawlik, Timothy M. [1 ]
Cosgrove, David [2 ]
机构：
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA
[2] Johns Hopkins Univ, Sch Med, Dept Med Oncol, Baltimore, MD 21287 USA
来源：
JOURNAL OF GASTROINTESTINAL SURGERY | 2011年 / 15卷 / 03期
关键词：
FLUOROURACIL PLUS LEUCOVORIN; III COLON-CANCER; HEPATIC RESECTION; ADJUVANT TREATMENT; PREOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; PHASE-III; SURVIVAL;
D O I：
10.1007/s11605-011-1423-z
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：410 / 415
页数：6
相关论文
共 50 条
  • [41] What is the optimal number of neoadjuvant chemotherapy cycles for resectable colorectal liver oligometastases?
    Chen, Qichen
    Li, Xingchen
    Zhao, Jianjun
    Bi, Xinyu
    Li, Zhiyu
    Huang, Zhen
    Zhang, Yefan
    Zhou, Jianguo
    Zhao, Hong
    Cai, Jianqiang
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (01)
  • [42] Final results of the EORTC Intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases
    Nordlinger, B.
    Sorbye, H.
    Collette, L.
    Glimelius, B.
    Poston, G. J.
    Schlag, P. M.
    Rougier, P.
    Bechstein, W.
    Walpole, E.
    Gruenberger, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [43] Effect of peri-operative high protein nutritional support on post-operative complications and costs of treatment in patients with colorectal cancer
    Manasek, V.
    Bezdek, K.
    Foltys, A.
    Klos, K.
    Smitka, J.
    Nmehlik, D.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S519 - S519
  • [44] OBESITY DOES NOT PREDICT WORSE PERI-OPERATIVE OUTCOMES IN LIVER TRANSPLANTATION: A TEN-YEAR ANALYSIS
    Kroner, Paul T.
    Mangan, James
    Khemichian, Saro
    Karagozian, Raffi
    GASTROENTEROLOGY, 2017, 152 (05) : S1129 - S1129
  • [45] Role of Peri-operative Chemotherapy in Stage II (pT2N0) Gallbladder Cancers
    Kunte, Aditya
    Patkar, Shraddha
    Chaudhari, Vikram
    Goel, Mahesh
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (01) : 78 - 88
  • [46] Role of Peri-operative Chemotherapy in Stage II (pT2N0) Gallbladder Cancers
    Aditya Kunte
    Shraddha Patkar
    Vikram Chaudhari
    Mahesh Goel
    Journal of Gastrointestinal Surgery, 2023, 27 : 78 - 88
  • [47] The relationships between patients' BMI, diabetes, liver directed chemotherapy, fatty liver disease and peri-operative outcomes after liver resection
    Lordan, Jeffrey
    Wiggans, Matthew
    Bowles, Matthew
    Aroori, Somaiah
    Stell, David
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 20 - 20
  • [48] Surgical resection and peri-operative chemotherapy for colorectal cancer (CRC) liver metastases in routine clinical practice: A population-based outcomes study.
    Booth, Christopher M.
    Li, Gavin
    Biagi, James Joseph
    Krzyzanowska, Monika K.
    Mackillop, William J.
    Nanji, Sulaiman
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [49] Efficacy of Perioperative Chemotherapy in Patients with Colorectal Cancer Undergoing Hepatectomy for Resectable Synchronous Liver Metastasis
    Nakanishi, Masayoshi
    Kuriu, Yoshiaki
    Murayama, Yasutoshi
    Konishi, Hirotaka
    Komatsu, Shuhei
    Shiozaki, Atsushi
    Ikoma, Hisashi
    Kubota, Takeshi
    Ichikawa, Daisuke
    Fujiwara, Hitoshi
    Okamoto, Kazuma
    Sakakura, Chohei
    Otsuji, Eigo
    HEPATO-GASTROENTEROLOGY, 2014, 61 (134) : 1582 - 1587
  • [50] Does chemotherapy affect outcome post liver resection for colorectal cancer liver metastasis?
    Bond-Smith, G.
    O'Reilly, D.
    Bowers, K.
    Hutchins, R.
    BRITISH JOURNAL OF SURGERY, 2010, 97 : 72 - 73
12345